<?xml version="1.0" encoding="UTF-8"?>
<fig id="f0001" fig-type="figure" orientation="portrait" position="float">
 <label>Figure 1.</label>
 <caption>
  <p>Effect of Ca
   <sub>v</sub>3.3-blocking peptide on mechanical allodynia in FRICT-ION mice. A Ca
   <sub>v</sub>3.3-blocking peptide, TAT-C3P, was administered to (A) male and (B) female mice via intraperitoneal injection at a dose of 10 mg/kg and monitored every hour for up to 5 h post-injection. For control experiments TAT-C3D was used, which does not block Ca
   <sub>v</sub>3.3 channels. (C) Effectiveness of 10 mg/kg Ca
   <sub>v</sub>3.3-blocking peptide at peak anti-allodynic effect (4 hrs post-injection) is compared versus naïve, TAT-C3D control, and versus male and female mice * p &lt; 0.05 and ** p &lt; 0.01 compared to FRIC+TAT-C3D, **** p &lt; 0.0001 compared to FRIC+TAT-C3D, ++ p &lt; 0.01 compared to males with FRIC+TAT-C3D. Lack of error in naïve behavioral measurements is because of a ceiling effect for mechanical threshold in these mice
  </p>
 </caption>
 <alternatives>
  <graphic specific-use="web-only" content-type="color" xlink:href="KCHL_A_1859248_F0001_OC" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <graphic specific-use="print-only" content-type="black-white" xlink:href="KCHL_A_1859248_F0001_PB" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </alternatives>
</fig>
